# Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

> **NCT00171496** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 693 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Cyclosporine microemulsion
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00171496
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 693 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171496, "Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00171496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*